Growth and safety evaluation in very low birth weight infants receiving an exclusive human milk diet: a phase III randomized control trial in Japan.
Katsumi Mizuno, Tokuo Miyazawa, Utako Kondo, Toshiya Nishikubo, Yutaka Yamamoto, Yuya Nakano, Takehiko Hiroma, Kazushige Ikeda, Masahiko Murase, Hitomi Jimi, Isamu Hokuto, Masafumi Miyata
J Perinatol 10.1038/s41372-026-02695-w
摘要
摘要
OBJECTIVE: To determine safety and efficacy of exclusive human milk diet (EHMD) for very low birth weight (VLBW, <1500 g) infants. DESIGN: Prospective, controlled, open trial of VLBW infants randomized to EHMD (mother's own milk [MOM]/donor milk [DM] with human milk-based fortifiers) or Standard Diet (MOM/DM with cow milk-based fortifier/formula). Outcomes included superiority of weight gain velocity from birth to 34 weeks gestational age, time to full feeds, and safety. RESULT: In total, 147 infants received EHMD (n = 77) or Standard Diet (n = 70). The EHMD group had superior mean weight gain velocity versus the Standard Diet (13.44 vs 11.96 g/kg/day, p = 0.006) and earlier mean time to full feeds (20.0 vs 25.9 days, p = 0.03); adverse events were not significantly different (32.5% vs 21.4%, p = 0.13). CONCLUSION: EHMD is viable for management of VLBW infants, providing improved growth without reduced safety. TRIAL REGISTRATION AND ID: Japan Registry of Clinical Trials: jRCT2031210384.
KM 提取结果
0 个 Figure · 0 个 KM 面板